Amylyx Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
Amylyx Pharmaceuticals, Inc. (AMLX) announced participation in the 22nd Annual Needham Virtual Healthcare Conference. Co-CEOs Joshua Cohen and Justin Klee will present on April 18, 2023, at 12:45 PM ET. Investors can access a live webcast of the event through the company’s investor relations page, with a replay available for 90 days post-event.
Amylyx focuses on innovative treatments for neurodegenerative diseases, headquartered in Cambridge, Massachusetts, with operations in Canada and EMEA. For more details, visit the company's website.
- None.
- None.
A live webcast of the presentation can be accessed under “Events” in the Investor section of the Company’s website, https://investors.amylyx.com/news-events/events, and will be available for replay for 90 days following the event.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20230411005241/en/
Media
Amylyx Media Team
+1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors
+1 (857) 320-6244
Investors@amylyx.com
Source:
FAQ
What is the date of the 22nd Annual Needham Virtual Healthcare Conference for AMLX?
Who from AMLX will present at the Needham Virtual Healthcare Conference?
What time will the AMLX presentation occur at the conference?
How can I access the AMLX presentation during the Needham Conference?